Valereum (LON: VLRM) raised £600,000 at 5p/share. Chairman James Bannon and chief executive Gary Cottle contributed £225,000 each and they will each receive 2.5 million warrants exercisable at 50p each and 2.5 million warrants exercisable at 100p each. Tokenisation marketplace VLRM Markets has generated $135,000 in revenues in four months to September 2025. The share price jumped 86.3% to 4.75p.
Shepherd Neame (LON: SHEP) executive director Jonathan Neame has bought 4,000 shares at 520p each. The share price increased 8.54% to 540p.
Igraine (LON: KING) has reduced its stake in Oscillate (LON: MUSH) from 5.05% to less than 3%. The Oscillate share price rose 2.74% to 0.375p. The Igraine share price improved 7.69% to 0.35p.
Global Connectivity (LON: GCON) has raised £200,000 at 1.5p/share. The share price rose 4.55% to 1.15p.
Music management and services provider All Things Considered (LON: ATC) is paying an initial $520,000 for certain assets of Control Industry Inc, which owns a merchandise management business. Client relationships include Diana Ross and Billy Joel. The total payment could be $760,000 depending on revenues over the coming nine months. This business fits with the existing Sandbag subsidiary and its boss will take over sales and marketing in the US for the group. The share price edged up 3.57% to 145p.
FALLERS
B HODL (LON: HODL) has taken its Bitcoin holding to 136 at a total cost of £11.5m. The share price declined 11.4% to 12.625p.
The Smarter Web Company (LON: SWC) has raised £2.56m at 102p/share via subscription and £9.68m from a placing at 100p/share. The share price is 9.76% lower at 12.625p.
Wishbone Gold (LON: WSBN) has expanded the drilling programme at the Red Setter Gold Dome project. The share price decreased 3.85% to 1.25p.
WH Ireland (LON: WHI) shareholders have voted against the sale of its wealth management division to Oberon Investments (LON: OBE). The two companies are assessing options. The share price slipped 2.41% to 4.05p.
Diagnostics firm EDX Medical (LON: EDX) has started marketing of the TC100 testicular cancer testing service. The blood test has shown 100% efficacy. The share price is down 2.22% to 11p.